Oliver Luxxe Assets’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56M Sell
49,744
-46,892
-49% -$1.38M 0.23% 123
2026
Q1
$2.39M Buy
96,636
+19,589
+25% +$467K 0.36% 109
2025
Q4
$1.8M Buy
77,047
+1,646
+2% +$36.7K 0.27% 125
2025
Q3
$1.49M Buy
75,401
+4,161
+6% +$85.6K 0.24% 131
2025
Q2
$1.55M Buy
71,240
+935
+1% +$22.1K 0.28% 117
2025
Q1
$1.7M Sell
70,305
-32,970
-32% -$742K 0.32% 111
2024
Q4
$2.12M Buy
103,275
+69,250
+204% +$1.49M 0.19% 137
2024
Q3
$676K Buy
+34,025
New +$631K 0.12% 148

Other funds holding CPRX